Skip to main content
PMC home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1986 Jun;22(2):119–124. doi: 10.1007/BF00199125

Promotion of tumor antigenicity in EL-4 leukemia cells by hydrostatic pressure

Lysiane Richert 1, Ayala Or 1, Meir Shinitzky 1,✉
PMCID: PMC11038643  PMID: 2424597

Abstract

Subjection of EL-4-leukemia cells to hydrostatic pressure of 1200–1500 atm for 15 min increased their weak basal immunogenicity to a potent practical level. Injection of such pressure-treated and irradiated EL-4 cells into syngeneic naive C57Bl/6 mice significantly delayed tumor development and increased survival after subsequent challenge with untreated EL-4 cells. Application of pressure of 1500 atm for a longer period of time (e.g., 120 min) resulted in cell death and a smaller increase in tumor immunogenicity which could be partially accounted for by passive shedding of membrane material. Unlike previously studied tumor cells, incorporation of cholesteryl hemisuccinate (CHS) into the plasma membrane of EL-4 cells increased their apparent tumor immunogenicity only slightly. In addition, isolated EL-4 plasma membranes, untreated, CHS-treated or pressure-treated, as well as the material shed thereof by hydrostatic pressure, were all of weak immunogenicity.

Modulation in the projection of surface antigens upon pressure treatment could account for the observed increase in tumor immunogenicity and was monitored via the Thy 1.2 antigen. Fluorescence cell sorting analysis indicated that upon application of 1500 atm for different periods of time the projection of Thy 1.2 progressively and irreversibly increased to a maximal level of about 140% at 15 min. At longer pressurizations the availability of Thy 1.2 to antibody binding decreased sharply to levels below that of the untreated cells. It is suggested that pressure promotion of tumor immunogenicity is induced by changes in projection and surface distribution of the relevant antigens.

Keywords: Hydrostatic Pressure, Tumor Immunogenicity, Subsequent Challenge, Cell Sorting Analysis, Relevant Antigen

Footnotes

Supported by a grant from the Institut National de lo Sante et de la Recherche Medicale FRANCE.

References

  • 1.Borochov H, Shinitzky M. Vertical displacement of membrane proteins mediated by changes in microviscosity. Proc Natl Acad Sci USA. 1976;73:4526. doi: 10.1073/pnas.73.12.4526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Cherry RJ, Muller U, Holenstein C, Heyn MP. Lateral segregation of proteins induced by cholesterol in bacteriorhodopsin-phospholipid vesicles. Biochim Biophys Acta. 1980;596:145. doi: 10.1016/0005-2736(80)90179-0. [DOI] [PubMed] [Google Scholar]
  • 3.Chong PLG, Cossins AR. A differential polarized phase fluorometric study of the effects of high hydrostatic pressure upon the fluidity of cellular membranes. Biochemistry. 1983;22:409. doi: 10.1021/bi00271a026. [DOI] [PubMed] [Google Scholar]
  • 4.Fidler IJ. Selection of successive tumor lines for metastasis. Nature. 1973;242:148. doi: 10.1038/newbio242148a0. [DOI] [PubMed] [Google Scholar]
  • 5.Gerlier D, Price MR, Bisky RH, Baldwin RW. Modification of cell cholesterol content of rat tumor cells. Effect upon their tumorigenicity and immunogenicity. Cancer Immunol Immunother. 1982;14:27. doi: 10.1007/BF00199428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Gerson DF. Interfacial free energies and the control of the positioning and aggregation of membran proteins. Biophys J. 1982;37:145. doi: 10.1016/S0006-3495(82)84643-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Gorer PA. The isoantigens of malignant cells. In: Harris RJC, editor. Biological approaches to cancer chemotherapy. London: Academic Press; 1961. p. 219. [Google Scholar]
  • 8.Haran-Ghera N, Ben-Yorakov M, Peled A. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. I. Cellulur analysis of immunosuppression. J Immunol. 1977;118:600. [PubMed] [Google Scholar]
  • 9.Leclesc JC, Levy JP, Varett B, Oppenheim S, Senik A. Antigenic analysis of L strain cells: A new murine leukemia-associated antigen, “L”. Cancer Res. 1970;30:2073. [PubMed] [Google Scholar]
  • 10.Maeda T, Balakrishnan K, Mehdi SQ. A simple and rapid method for the preparation of plasma membranes. Biochim Biophys Acta. 1983;731:115. doi: 10.1016/0005-2736(83)90404-2. [DOI] [PubMed] [Google Scholar]
  • 11.Martin WJ, Wunderlich JR, Flechler F, Inman JK. Enhanced immunogenicity of chemically-coated syngeneic tumor cells. Proc Natl Acad Sci USA. 1971;68:469. doi: 10.1073/pnas.68.2.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Muller CR, Shinitzky M. Passive shedding of erythrocyte antigens induced by membrane rigidification. Exp Cell Res. 1981;136:53. doi: 10.1016/0014-4827(81)90037-9. [DOI] [PubMed] [Google Scholar]
  • 13.Muller CP, Stephany DA, Shinitzky M, Wunderlich JR. Changes in cell-surface expression of MHC and Thy-1.2 determinants following treatment with lipid modulating agents. J Immunol. 1983;131:1356. [PubMed] [Google Scholar]
  • 14.Richert L, Castagna M, Beck JP, Rong S, Bang L, Ourisson G. Growth-rate-related and hydroxysterol-induced changes in membrane fluiditiy of cultured hepatoma cells: correlation with 3-hydroxy-3-methyl-glutaryl CoA reductase activity. Biochem Biophys Res Comm. 1984;120:192. doi: 10.1016/0006-291x(84)91432-3. [DOI] [PubMed] [Google Scholar]
  • 15.Salmon ED. Pressure-induced depolymerization of spindle microtubules. J Cell Biol. 1975;65:603. doi: 10.1083/jcb.65.3.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sandermann H. Regulation of membrane enzymes by lipids. Biochim Biophys Acta. 1978;515:209. doi: 10.1016/0304-4157(78)90015-1. [DOI] [PubMed] [Google Scholar]
  • 17.Schick B, Berke G. Activity of tumor-associated lymphoid cells at short intervals after administration of irradiated syngeneic and allogeneic tumor cells. J Immunol. 1977;118:986. [PubMed] [Google Scholar]
  • 18.Shearer GM, Schmitt-Verhulst AM. Major histocompatibility complex restricted cell-mediated immunity. Adv Immunol. 1977;25:55. doi: 10.1016/s0065-2776(08)60931-1. [DOI] [PubMed] [Google Scholar]
  • 19.Shiku H, Takahashi T, Oettgen HF, Old LJ. Cell surface antigens of human malignant melanoma. J Exp Med. 1976;144:873. doi: 10.1084/jem.144.4.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Shinitzky M. Membrane fluidity in malignancy — adversative and recuperative. Reviews on Cancer. Biochim Biophys Acta. 1984;738:251. doi: 10.1016/0304-419x(83)90007-0. [DOI] [PubMed] [Google Scholar]
  • 21.Shinitzky M. Membrane fluidity and receptor function. In: Kates M, Manson LA, editors. Biomembranes. New York: Plenum Press; 1984. p. 585. [Google Scholar]
  • 22.Shinitzky M, Barenholz Y. Fluiditiy parameters of lipid regions determined by fluorescence polarization. Biochim Biophys Acta. 1978;515:367. doi: 10.1016/0304-4157(78)90010-2. [DOI] [PubMed] [Google Scholar]
  • 23.Shinitzky M, Souroujon M. Passive modulation of blood-group antigens. Proc Nal Acad Sci USA. 1979;76:4438. doi: 10.1073/pnas.76.9.4438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Shinitzky M, Skornick Y. Regulation of tumor growth by lipids. Positive clinical applications. Dev Cancer Res. 1982;7:61. [Google Scholar]
  • 25.Shinitzky M, Skornick Y, Haran-Ghera N. Effective tumor immunization induced by cells of elevated membrane microviscosity. Proc Natl Acad Sci USA. 1979;76:5315. doi: 10.1073/pnas.76.10.5313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Skornick Y, Sindelar WF. Effective tumor immunization in hamsters and positive skin test in cancer patients induced by tumor cells in increased membrane microviscosity. Surgical Forum. 1981;32:432. [Google Scholar]
  • 27.Skornick Y, Danciger E, Rozin RR, Shinitzky M. Positive skin tests with autologous tumor cells of increased membrane viscosity: first report. Cancer Immunol Immunother. 1981;11:93. [Google Scholar]
  • 28.Skornick Y, Gorelik E, Sindelar WF. Reduction of metastases in murine malignancies by immunotherapy with syngeneic tumor cells treated with cholesterol hemisuccinate. Surgical Forum. 1982;33:396. [Google Scholar]
  • 29.Skornick Y, Dresdale AR, Sindelar WF. Induction of delayed hypersensitivity reactions in cancer patients by cholesterol hemisuccinated treated autologous tumor cells. J Natl Cancer Inst. 1983;70:465. [PubMed] [Google Scholar]
  • 30.Skornick Y, Kurman CC, Sindelar WF. Active immunization of hamsters against pancreatic carcinoma with lipid-treated cells of their shed antigens. Cancer Res. 1984;44:946. [PubMed] [Google Scholar]
  • 31.Skornick Y, Gorelik E, Klausner J, Shinitzky M, Sindelar WF. Inhibition of growth and metastases in mice by immunization with cholesterol hemissucinate enriched tumor cells. Cancer Lett. 1984;25:153. doi: 10.1016/s0304-3835(84)80040-3. [DOI] [PubMed] [Google Scholar]
  • 32.Weber G, Drickamer HG. The effect of high pressure upon proteins and other biomolecules. Q Rev Biophys. 1983;16:89. doi: 10.1017/s0033583500004935. [DOI] [PubMed] [Google Scholar]
  • 33.Wunderlich F, Ronai A, Speth V, Seelig J, Blumen A. Thermotropic lipid clustering in tetrahymena membranes. Biochemistry. 1975;14:3730. doi: 10.1021/bi00688a002. [DOI] [PubMed] [Google Scholar]
  • 34.Yuli I, Wilbrandt W, Shinitzky M. Glucose transport through cell membranes of modified lipid fluidity. Biochemistry. 1981;20:4250. doi: 10.1021/bi00518a003. [DOI] [PubMed] [Google Scholar]
  • 35.Zinkernagel RM, Doharty PC. MHC-restricted cytotoxic T-cells: Studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction specificity, function and responsiveness. Adv Immunol. 1979;27:52. doi: 10.1016/s0065-2776(08)60262-x. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES